Skip to content
23.03.2017

Joint Statement on New Momentum for the European Research Area

CESAER, EUA, LERU, and Science Europe release this joint statement calling on European policy makers to provide new momentum for the European Research Area (ERA). The ERA is a treaty obligation of the European Union and today, more than ever, greater commitment to research is needed to tackle the challenges that Europe faces. By strengthening the ERA, and increasing funding for research, European policy makers would be giving Europe the resources it needs to embark on another 60 years of peace and prosperity.

DOI: 10.5281/zenodo.4980165

Download resource

Member-only content is available on this page. Please log in to view this content.

Related content

01.07.2022

Science Europe 2021 Annual Report

For Science Europe, 2021 was a very important year: the association celebrated its 10th year of existence. Founded in 2011, it has grown into a respected and influential voice in the European research policy debate. Moreover, we published a new Strategy Plan for 2021–2026, which maps our collective objectives and sets a specific yet flexible action framework over the next five years.

10.06.2022

Reaction to the Council Conclusions on Research Assessment and the Implementation of Open Science Policies

The Council Conclusions are an important step in recognising the relevance of Open Science and reforming research assessment, which are two essential elements of the cultural shift that are necessary to put research quality and openness are the cornerstones of positive research cultures.

16.12.2021

Report of the 2021 High Level Workshop on ERA: Research Culture in the ERA

The 2021 High Level Workshop on the European Research Area dealt with the topic of research culture and how to keep the research sector attractive for current and future generations of researchers.

22.11.2021

An ERA Governance Fit for Purpose

Science Europe Position on the Involvement of Stakeholders in the ERA Governance

04.10.2021

Open letter on ERA governance

With this letter, the undersigned representatives of research and innovation (R&I) organisations wish to reiterate the added value of including European R&I stakeholders in the ERA governance system, especially in both its co-creation and implementation.

23.07.2021

An Inclusive ERA for Excellent Research

Science Europe’s Reaction to the Commission Proposal for a Council Recommendation on a Pact for Research and Innovation.

17.06.2021

Science Europe Strategy Plan 2021-2026

The Science Europe Strategy Plan comes at a crucial time for European Research an Innovation (R&I) and includes an updated vision, mission, values, and set of strategic priorities for the association. It supports its Member Organisation in their mission to create world-class scientific knowledge, delivering more benefit for our societies.

17.06.2021

Multi-annual Action Plan 2021-2026

This Multi-annual Action Plan proposes a series of framework actions to guide the implementation of the Science Europe Strategy Plan 2021–2026 in line with the association's updated vision, mission, values, and strategic priorities.

11.05.2021

Response to the EC Consultation on the ERA Pact for Research and Innovation

The European Commission approach to the ‘ERA Pact for Research and Innovation in Europe’ should be as inclusive as possible. Its development and implementation need to include research communities, national governments, research organisations, and R&I stakeholders.

18.06.2020

Strengthening European Research: Funding Boost Needed to Guarantee Sustainability

Science Europe calls on the leaders of the EU to dedicate increased funding to research and innovation at the 19 June European Council meeting on the EU long-term budget and COVID-19 recovery fund.

An increased budget is necessary to meet the ambitious objectives of the European Union for a sustainable, healthy planet, and to ensure the global competitiveness of its research sector.

Science Europe also emphasises the need for sustained European leadership in tackling all COVID-19-incurred challenges.